'A done deal': FDA advisory committee votes unanimously against efficacy data for OTC nasal decongestant
Members of an FDA advisory committee on Tuesday voted unanimously against the efficacy of an over-the-counter nasal decongestant that’s been on the US market for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
